Invention Grant
- Patent Title: Biomarker panel for diagnosing cancer
-
Application No.: US15561755Application Date: 2016-03-23
-
Publication No.: US10408839B2Publication Date: 2019-09-10
- Inventor: Hermann Brenner , Hongda Chen
- Applicant: Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts
- Applicant Address: DE Heidelberg
- Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
- Current Assignee: DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES ÖFFENTLICHEN RECHTS
- Current Assignee Address: DE Heidelberg
- Agency: Saul Ewing Arnstein & Lehr LLP
- Agent Marry K. Murray
- Priority: EP15161465 20150327
- International Application: PCT/EP2016/056314 WO 20160323
- International Announcement: WO2016/156128 WO 20161006
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N33/574
Abstract:
An in vitro method for the diagnosis, prognosis, stratification and/or monitoring of colorectal cancer in a subject includes detecting the level of AREG, CEA, HGF-receptor, ErbB4-Her4, CD69, PSA, EMMPRIN, and INF-gamma biomarkers in a biological sample of the subject. In an embodiment, the subject is administered a treatment when a differential level of the biomarkers compared to a healthy control or a reference value is indicative for the presence of colorectal cancer in the subject.
Public/Granted literature
- US20180080937A1 Biomarker Panel For Diagnosing Cancer Public/Granted day:2018-03-22
Information query
IPC分类:
